Education
About Us
Working with TipRanks
Follow Us
Mark Stenhouse Insider Profile
4 Followers
Mark Stenhouse, President, Cologuard at Exact Sciences, holds 30.00K shares in Phathom Pharmaceuticals (Ticker: PHAT), holds 0.00 shares in Prometheus Biosciences (Ticker: RXDX), holds 29.93K shares in Exact Sciences (Ticker: EXAS).
Mark Stenhouse has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark Stenhouse holds in companies
Most Profitable Insider Trade
Stock:
Prometheus Biosciences
(RXDX)
(RXDX)
Rating:Informative Buy
Date:Mar 16, 2021 - Mar 16, 2022
Return:+84.80%
The most profitable trade made by Mark Stenhouse
Mark Stenhouse's Trading History
Exact Sciences
Apr 06, 2020
President, Cologuard
Uninformative Buy
751.80K
$1.45M
Phathom Pharmaceuticals
Jun 05, 2025
Director
Uninformative Buy
―
$288.90K
Prometheus Biosciences
Jun 16, 2023
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Mark Stenhouse's performance on stock
You May Also Like
Mark Stenhouse insider profile FAQ
What is the percentage of profitable transactions made by Mark Stenhouse?
The percentage of profitable transactions made by Mark Stenhouse is ―.
What is the average return per transaction made by Mark Stenhouse?
The average return per transaction made by Mark Stenhouse is ―.
What stocks does Mark Stenhouse hold?
Mark Stenhouse holds: EXAS, PHAT, RXDX stocks.
What was Mark Stenhouse’s latest transaction?
Mark Stenhouse latest transaction was an Uninformative Buy of ―.
What was Mark Stenhouse's most profitable transaction?
Mark Stenhouse’s most profitable transaction was an Informative Buy of RXDX stock on March 16, 2021. The return on the trade was 84.80%.
What is Mark Stenhouse's role in Exact Sciences?
Mark Stenhouse's role in Exact Sciences is President, Cologuard.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.